Neurology: Volume 86, Number 10, March 8, 2016 Exam #1
About this course
- Released: 3/8/2016
- Expires: 3/8/2019
RESULTS FROM A PHASE 1 STUDY OF NUSINERSEN (ISIS-SMNRX) IN CHILDREN WITH SPINAL MUSCULAR ATROPHY
Upon completion of the article by Chiriboga et al, the participant should be able to:
- List the most common adverse effects seen with nusinersen administration in this study
- State the CSF half-life of nusinersen seen in this study
- Discuss the effect of nusinersen administration on motor function in children with spinal muscular atrophy (SMA)
The article by Chiriboga et al covers the following core competency:
- Medical Knowledge
Refer to listing above the references in each article.
THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES
The American Academy of Neurology Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MISSION STATEMENT/PROGRAM OBJECTIVES
After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.
This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.
AMA CREDIT DESIGNATION STATEMENT
The American Academy of Neurology Institute designates this journal-based-CME activity for a maximum of .75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Steven Lewis, MD receives a stipend in his editorial capacity for Neurology and as Editor-in-Chief of Continuum: Lifelong Learning in Neurology; has received royalties for the books Field Guide to the Neurologic Examination and Neurology for the Non-Neurologist; and anticipates receiving royalties for the book Neurologic Disorders due to Systemic Disease. James WM Owens Jr. MD, PhD receives royalties from UpToDate, Waltham, MA; grant support from NIH (PI, K08NS054882); and a stipend in his editorial capacity for Neurology.
This CME program receives no commercial support.